HUEMER FLORIAN
Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center
Publications
43 Publications
2023
Journal Articles
Prognostic value of [
Mirshahvalad, SA; Seyedinia, SS; Huemer, F; Schweighofer-Zwink, G; Koch, O; Hitzl, W; Weiss, L; Emannuel, K; Greil, R; Pirich, C; Beheshti, M;
Eur J Radiol. 2023; 163:110843
Full papers/articles (Journal)
2022
Journal Articles
Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol.
Huemer, F; Hecht, S; Scharinger, B; Schlintl, V; Rinnerthaler, G; Schlick, K; Heregger, R; Melchardt, T; Wimmer, A; Mühlbacher, I; Koch, OO; Neureiter, D; Klieser, E; Seyedinia, S; Beheshti, M; Greil, R; Weiss, L;
J Cancer Res Clin Oncol. 2022;
Full papers/articles (Journal)
How We Treat Localized Rectal Cancer-An Institutional Paradigm for Total Neoadjuvant Therapy.
Roeder, F; Gerum, S; Hecht, S; Huemer, F; Jäger, T; Kaufmann, R; Klieser, E; Koch, OO; Neureiter, D; Emmanuel, K; Sedlmayer, F; Greil, R; Weiss, L;
Cancers (Basel). 2022; 14(22):
Reviews
Checkpoint inhibitors in metastatic gastric and GEJ cancer: a multi-institutional retrospective analysis of real-world data in a Western cohort.
Schlintl, V; Huemer, F; Rinnerthaler, G; Melchardt, T; Winder, T; Reimann, P; Riedl, J; Amann, A; Eisterer, W; Romeder, F; Piringer, G; Ilhan-Mutlu, A; Wöll, E; Greil, R; Weiss, L;
BMC Cancer. 2022; 22(1): 51
Full papers/articles (Journal)
Conference papers, proceedings, abstracts
Endothelin-1 genetic polymorphism (SNP rs5370-TT) fails to predict resistance to bevacizumab in metastatic breast cancer patients treated within the TANIA phase III trial
Gampenrieder, SP; Steiner, M; Hufnagl, C; Hackl, H; Rinnerthaler, G; Westphal, T; Huemer, F; Monzo-Fuentes, C; Morre, P; Hauser-Kronberger, C; Greil, R
ANN ONCOL. 2022; 33: S141-S141.
Abstracts (Journal)
The influence of pancreatic regression characteristics on outcome of neoadjuvant treated pancreatic cancer in two Austrian university centres
Neumayer, B; Neureiter, D; Klieser, E; Huemer, F; Weiss, L; Greil, R; Djanani, A; Oberhuber, G; Schlick, K
Virchows Archiv. 2022; 481(Supplement 1):S135-S135.-34th European Congress of Pathology; 03.-07.09.2022; Basel.
Full papers/articles (Journal)
Prognostic and predictive value of 18F-FDG PET/CT in assessment of treatment response and PFS in gastric cancer patient underwent neoadjuvant chemotherapy using FLOT regimen
Seyedinia, S; Huemer, F; Mirshahvalad, S; Koch, O; Weiss, L; Emmanuel, K; Pirich, C; Greil, R; Beheshti, M
EUR J NUCL MED MOL I. 2022; 49(SUPPL 1): S473-S473.
Abstracts (Journal)
2021
Journal Articles
Sustained response to brigatinib in a patient with refractory metastatic pheochromocytoma harboring R1192P anaplastic lymphoma kinase mutation: a case report from the Austrian Group Medical Tumor Therapy next-generation sequencing registry and discussion of the literature.
Heregger, R; Huemer, F; Hutarew, G; Hecht, S; Cheveresan, L; Kotzot, D; Schamschula, E; Rinnerthaler, G; Melchardt, T; Weiss, L; Greil, R;
ESMO Open. 2021; 6(4):100233
Reviews
miRNA-Based Therapeutics in the Era of Immune-Checkpoint Inhibitors.
Huemer, F; Leisch, M; Geisberger, R; Zaborsky, N; Greil, R;
Pharmaceuticals (Basel). 2021; 14(2):
Reviews
Results of a hospitalization policy of asymptomatic and pre-symptomatic COVID-19-positive long-term care facility residents in the province of Salzburg-a report from the AGMT COVID-19 Registry.
Huemer, F; Rinnerthaler, G; Jörg, B; Morre, P; Stegbuchner, B; Proksch, E; Fleimisch, S; Oberkofler, H; Kremser, I; Greil, R; Egle, A;
Geroscience. 2021; 43(4):-1897
Full papers/articles (Journal)
Deregulated glutamate to pro-collagen conversion is associated with adverse outcome in lung cancer and may be targeted by renin-angiotensin-aldosterone system (RAS) inhibition.
Kocher, F; Tymoszuk, P; Amann, A; Sprung, S; Salcher, S; Daum, S; Haybaeck, J; Rinnerthaler, G; Huemer, F; Kauffmann-Guerrero, D; Tufman, A; Seeber, A; Wolf, D; Pircher, A;
Lung Cancer. 2021; 159:84-95
Full papers/articles (Journal)
Sex-Based Clinical Outcome in Advanced NSCLC Patients Undergoing PD-1/PD-L1 Inhibitor Therapy-A Retrospective Bi-Centric Cohort Study.
Lang, D; Brauner, A; Huemer, F; Rinnerthaler, G; Horner, A; Wass, R; Brehm, E; Kaiser, B; Greil, R; Lamprecht, B;
Cancers (Basel). 2021; 14(1):
Full papers/articles (Journal)
Spatial Heterogeneity in Large Resected Diffuse Large B-Cell Lymphoma Bulks Analysed by Massively Parallel Sequencing of Multiple Synchronous Biopsies.
Magnes, T; Wagner, S; Thorner, AR; Neureiter, D; Klieser, E; Rinnerthaler, G; Weiss, L; Huemer, F; Schlick, K; Zaborsky, N; Steiner, M; Greil, R; Egle, A; Melchardt, T;
Cancers (Basel). 2021; 13(4):
Full papers/articles (Journal)
Clonal evolution in diffuse large B-cell lymphoma with central nervous system recurrence.
Magnes, T; Wagner, S; Thorner, AR; Neureiter, D; Klieser, E; Rinnerthaler, G; Weiss, L; Huemer, F; Zaborsky, N; Steiner, M; Weis, S; Greil, R; Egle, A; Melchardt, T;
ESMO Open. 2021; 6(1): 100012
Full papers/articles (Journal)
Postoperative chemoradiotherapy with cisplatin is superior to radioimmunotherapy with cetuximab and radiotherapy alone : Analysis of the Austrian head and neck cancer registry of the AGMT.
Magnes, T; Wagner, SM; Melchardt, T; Weiss, L; Rinnerthaler, G; Huemer, F; Kopp, M; Gampenrieder, SP; Mayrbäurl, B; Füreder, T; Lenger, D; Andel, J; Egle, A; Greil, R;
Wien Klin Wochenschr. 2021; 133(21-22):-1136.
Full papers/articles (Journal)
Non-pegylated Liposomal Doxorubicin as Palliative Chemotherapy in pre-Treated Advanced Pancreatic Cancer: A Retrospective Analysis of Twenty-Eight Patients.
Schlick, K; Kiem, D; Huemer, F; Neureiter, D; Weiss, L; Greil, R;
Technol Cancer Res Treat. 2021; 20: 15330338211042139
Full papers/articles (Journal)
Evaluation of circulating cell-free KRAS mutational status as a molecular monitoring tool in patients with pancreatic cancer.
Schlick, K; Markus, S; Huemer, F; Ratzinger, L; Zaborsky, N; Clemens, H; Neureiter, D; Neumayer, B; Beate, AS; Florian, S; Martin, V; Grundbichler, M; Weiss, L; Melchardt, T; Greil, R; Egle, A;
Pancreatology. 2021; 21(8):1466-1471
Full papers/articles (Journal)
Ramucirumab plus FOLFIRI or irinotecan as second-line therapy in advanced or metastatic gastric or gastroesophageal junction adenocarcinoma.
Schlintl, V; Huemer, F; Greil, R; Weiss, L;
J Gastrointest Oncol. 2021; 12(2): 906-909.
Letters
2020
Journal Articles
Impact of PD-L1 Scores and Changes on Clinical Outcome in Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy.
Huemer, F; Klieser, E; Neureiter, D; Schlintl, V; Rinnerthaler, G; Pagès, F; Kirilovsky, A; El Sissy, C; Iglseder, W; Singhartinger, F; Jäger, T; Dinnewitzer, A; Zaborsky, N; Steiner, M; Greil, R; Weiss, L;
J Clin Med. 2020; 9(9):
Full papers/articles (Journal)
Combination Strategies for Immune-Checkpoint Blockade and Response Prediction by Artificial Intelligence.
Huemer, F; Leisch, M; Geisberger, R; Melchardt, T; Rinnerthaler, G; Zaborsky, N; Greil, R;
Int J Mol Sci. 2020; 21(8):
Reviews
Hospitalizations and Clinical Outcome in Metastatic Colorectal Cancer During Regorafenib or TAS-102 Therapy.
Huemer, F; Piringer, G; Schlintl, V; Hackl, H; Rinnerthaler, G; Thaler, J; Greil, R; Weiss, L;
Cancers (Basel). 2020; 12(10):
Full papers/articles (Journal)
Local and Central Evaluation of HER2 Positivity and Clinical Outcome in Advanced Gastric and Gastroesophageal Cancer-Results from the AGMT GASTRIC-5 Registry.
Huemer, F; Weiss, L; Regitnig, P; Winder, T; Hartmann, B; Thaler, J; Piringer, G; Schmitt, CA; Eisterer, W; Gänzer, H; Wüstner, A; Andel, J; Jagdt, B; Ulmer, H; Greil, R; Wöll, E;
J Clin Med. 2020; 9(4):
Full papers/articles (Journal)
Low Expression of miR-20a-5p Predicts Benefit to Bevacizumab in Metastatic Breast Cancer Patients Treated within the TANIA Phase III Trial.
Rinnerthaler, G; Gampenrieder, SP; Hackl, H; Steiner, M; Monzo-Fuentes, C; Melchardt, T; Magnes, T; Huemer, F; Westphal, T; Hufnagl, C; Hauser-Kronberger, C; Egle, A; Greil, R;
J Clin Med. 2020; 9(6):
Full papers/articles (Journal)
Conference papers, proceedings, abstracts
Hospitalizations and clinical outcome in metastatic colorectal cancer during regorafenib or TAS-102 therapy
Huemer, F; Piringer, G; Schlintl, V; Hackl, H; Rinnerthaler, G; Thaler, J; Greil, R; Weiss, L
ONCOL RES TREAT. 2020; 43(SUPPL 4): 128-128.
Abstracts (Journal)
2019
Journal Articles
Baseline Absolute Lymphocyte Count and ECOG Performance Score Are Associated with Survival in Advanced Non-Small Cell Lung Cancer Undergoing PD-1/PD-L1 Blockade.
Huemer, F; Lang, D; Westphal, T; Gampenrieder, SP; Hutarew, G; Weiss, L; Hackl, H; Lamprecht, B; Rinnerthaler, G; Greil, R;
J Clin Med. 2019; 8(7):
Full papers/articles (Journal)
Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIM.
Huemer, F; Melchardt, T; Jansko, B; Wahida, A; Jilg, S; Jost, PJ; Klieser, E; Katja, S; Magnes, T; Pleyer, L; Greil-Ressler, S; Rass, C; Greil, R; Egle, A;
Eur J Haematol. 2019; 102(5): 437-441.
Full papers/articles (Journal)
Association between antibiotics use and outcome in patients with NSCLC treated with immunotherapeutics.
Huemer, F; Rinnerthaler, G; Lang, D; Hackl, H; Lamprecht, B; Greil, R;
Ann Oncol. 2019; 30(4): 652-653.
Letters
Regorafenib Is Associated With Increased Skeletal Muscle Loss Compared to TAS-102 in Metastatic Colorectal Cancer.
Huemer, F; Schlintl, V; Hecht, S; Hackl, H; Melchardt, T; Rinnerthaler, G; Greil, R; Weiss, L;
Clin Colorectal Cancer. 2019; 18(2):159-166.e3
Full papers/articles (Journal)
Therapy Line and Associated Predictors of Response to PD-1/PD-L1-Inhibitor Monotherapy in Advanced Non-small-Cell Lung Cancer: A Retrospective Bi-centric Cohort Study.
Lang, D; Huemer, F; Rinnerthaler, G; Horner, A; Wass, R; Brehm, E; Akbari, K; Granitz, M; Hutarew, G; Kaiser, B; Greil, R; Lamprecht, B;
Target Oncol. 2019; 14(6): 707-717.
Full papers/articles (Journal)
C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling overall survival Prediction in Pancreatic Cancer Patients.
Schlick, K; Magnes, T; Huemer, F; Ratzinger, L; Weiss, L; Pichler, M; Melchardt, T; Greil, R; Egle, A;
J Clin Med. 2019; 8(11):
Full papers/articles (Journal)
Conference papers, proceedings, abstracts
Therapy line and associated predictors of response to PD-1/PD-L1 inhibitor monotherapy in advanced NSCLC - a retrospective bi-centric cohort study
Lang, D; Huemer, F; Rinnerthaler, G; Horner, A; Wass, R; Brehm, E; Akbari, K; Granitz, M; Hutarew, G; Kaiser, B; Greil, R; Lamprecht, B
WIEN KLIN WOCHENSCHR. 2019; 131(19-20): 521-522.
Abstracts (Journal)
2018
Journal Articles
Impact of antibiotic treatment on immune-checkpoint blockade efficacy in advanced non-squamous non-small cell lung cancer.
Huemer, F; Rinnerthaler, G; Westphal, T; Hackl, H; Hutarew, G; Gampenrieder, SP; Weiss, L; Greil, R;
Oncotarget. 2018; 9(23):-16520
Full papers/articles (Journal)
Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie).
Huemer, F; Thaler, J; Piringer, G; Hackl, H; Pleyer, L; Hufnagl, C; Weiss, L; Greil, R;
BMC Cancer. 2018; 18(1): 11
Full papers/articles (Journal)
Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia.
Huemer, F; Weiss, L; Faber, V; Neureiter, D; Egle, A; Geissler, K; Voskova, D; Zebisch, A; Burgstaller, S; Pichler, A; Stauder, R; Sperr, W; Lang, A; Pfeilstöcker, M; Machherndl-Spandl, S; Stampfl, M; Greil, R; Pleyer, L;
Wien Klin Wochenschr. 2018; 130(3-4): 115-125.
Full papers/articles (Journal)
Extensive Leptomeningeal Intracranial and Spinal Metastases in a Patient with a Supratentorial Glioblastoma Multiforme, IDH-Wildtype.
Schwartz, C; Romagna, A; Machegger, L; Weiss, L; Huemer, F; Fastner, G; Kleindienst, W; Serge, W; Greil, R; Winkler, PA;
World Neurosurg. 2018; 120:442-447
Case Reports
2017
Journal Articles
Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer.
Gampenrieder, SP; Hufnagl, C; Brechelmacher, S; Huemer, F; Hackl, H; Rinnerthaler, G; Romeder, F; Monzo Fuentes, C; Morre, P; Hauser-Kronberger, C; Mlineritsch, B; Greil, R;
Pharmacogenomics J. 2017; 17(4):344-350
Full papers/articles (Journal)
Intermittent low-dose bevacizumab in hereditary hemorrhagic telangiectasia : A case report.
Huemer, F; Dejaco, M; Grabmer, C; Melchardt, T; Neureiter, D; Mayer, G; Egle, A; Greil, R; Weiss, L;
Wien Klin Wochenschr. 2017; 129(3-4):-144
Case Reports
ASCO-update: gastrointestinal tumors.
Weiss, L; Huemer, F; Greil, R;
Memo. 2017; 10(4): 240-243.
Reviews
Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients - AGMT_GASTRIC-3.
Wöll, E; Thaler, J; Keil, F; Gruenberger, B; Hejna, M; Eisterer, W; Fridrik, MA; Ulmer, H; Trommet, V; Huemer, F; Weiss, L; Greil, R;
Anticancer Res. 2017; 37(10): 5553-5558.
Full papers/articles (Journal)
2016
Journal Articles
Immune checkpoint blockade in ovarian cancer.
Weiss, L; Huemer, F; Mlineritsch, B; Greil, R;
Memo. 2016; 9:82-84
Reviews
2015
Journal Articles
Anti-Hu Antibody Associated Paraneoplastic Cerebellar Degeneration in Head and Neck Cancer.
Huemer, F; Melchardt, T; Tränkenschuh, W; Neureiter, D; Moser, G; Magnes, T; Weiss, L; Schlattau, A; Hufnagl, C; Ricken, G; Höftberger, R; Greil, R; Egle, A;
BMC Cancer. 2015; 15:996
Case Reports
Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPI.
Melchardt, T; Troppan, K; Weiss, L; Hufnagl, C; Neureiter, D; Tränkenschuh, W; Schlick, K; Huemer, F; Deutsch, A; Neumeister, P; Greil, R; Pichler, M; Egle, A;
J Natl Compr Canc Netw. 2015; 13(12):1501-1508
Full papers/articles (Journal)
2014
Journal Articles
Overcoming resistance against HER2-targeting agents in fifth-line therapy: is there still a place for bevacizumab in HER2+ breast cancer?
Huemer, F; Gampenrieder, SP; Schlattau, A; Greil, R;
Clin Breast Cancer. 2014; 14(1):e17-e20
Case Reports